Video
Author(s):
Dr Shore continues his review of data on cabazitaxel for the treatment of mCRPC by highlighting efficacy data from the CARD trial and real-world data that could impact practice.
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.